Maruti Suzuki India Limited shares fell 2% to Rs11,126.05, an 18-month low since April 2025, and are down 33% so far in calendar 2026 versus 15% fall in BSE Sensex and 12% in BSE Auto, on concerns that West Asia geopolitical tensions could raise commodity prices and pressure near-term profitability. The company said in its FY26 annual report it is working to regain 50% market share by serving SUVs, small cars and other segments while strengthening localisation and supply-chain resilience amid concentrated supplies of specialised materials.

HSBC cut its target on Maruti Suzuki India Limited by 9.4% to Rs 14,500 while retaining a Buy rating, calling it the best proxy for India's passenger vehicle recovery. HSBC expects September-quarter volume up 26.5% but EBITDA down 10.0% with margin at 8.8% versus 12.7% a year earlier, and cut FY27 EPS by 14% and FY28 EPS by 17% while raising WACC to 10.5% from 9.65%.

Maruti Suzuki India Limited has developed a hybrid ambulance prototype that was examined by Prime Minister Narendra Modi on 26 August 2025 and would qualify for PM E-DRIVE incentives, but the model has yet to be launched.

Motilal Oswal projects Maruti Suzuki India Limited will report a 19% year-on-year fall in September-quarter net profit despite revenue rising 27.7%, indicating margin pain despite sales growth.

Bernstein says Maruti Suzuki India Limited faces a more nuanced setup as its mass-market exposure makes it more sensitive to fading GST affordability benefits, while its addition of 500,000 units of annual capacity raises the importance of utilisation, exports and inventory discipline.

Maruti Suzuki India Limited increased prices by up to Rs 30,000 effective August 1, and its senior executive Partho Banerjee said rainfall deficit will not impact its festive season, though growth percentage may moderate on a high base.